Department of Science - Research & Development

Dr. Julio L. Garcia is the chief medical officer for Biomolecular LLC. Graduated from the University of Havana, Cuba in 1985 holding a master of intensive care, and a master in Nephrology during 1984. He obtained his pediatric doctor grade 1 in the Ministry of Health, Republic of Cuba, during 1983. Dr. Garcia holds a degree in doctor in medicine , completed on 1971-1976 from Central University of Las Villas, Cuba. Dr. Garcia has over 40 years of experience in the medical field. Supervise all aspects of the medical research, trials and post approval medical procedures. Function as chief advisory and educator for medical staff, ensuring correct clinical judgment apply to all major medical decisions within the health center. Manage evaluation, analysis and interpretation of clinical data, communicating results to teams and executive staff. Lead the medical review of current operations to ensure integrity of processes and compliance to medical guidelines. Oversee the evaluation, quality, testing, and execution of innovative and experimental medical services. Evaluate Physician actions and oversee authorizations for advancement of certain treatments. Provide guidance to research teams, develop medical input on relevant concepts, and drive team towards innovations. Create strategies, protocols, reports and presentations, while managing regulatory submissions and authoring formal publications. 

1. United States Patent and Trademark Office, 2014, U.S. Pat. No. 8,768,468, entitled Device for Neuro-Physiologic Stimulation. 
2. United States Patent and Trademark Office, 2014, U.S. Pat. No. 8,688,240, entitled Device for Neuro-Physiologic Stimulation. 
3. United States Patent and Trademark Office, 2013, U.S. Pat. No. 8,457,745, entitled Method, System And Apparatus for Control of Pancreatic Beta Cell Function To Improve Glucose Homeostasis and Insulin Production. 
4. United States Patent and Trademark Office, 2012, U.S. Patent. reference application No. 61/619,352, entitled Bio-Cellular Treatments for Diabetes Mellitus. 
5. United States Patent and Trademark Office, 2012, U.S. Patent. Design No. 29/442,086, entitled Bio-Electric Compass Applicator. 

1. Americus International University of Belize  2006-2007, Master of Science Advanced Nurse Practitioner, and Bachelor of Science, Nursing Science.   
2. Lady Malina Memorial Medical College  University of Science, Arts, and Technology, Olveston, Montserrat B.W.I, Master of Public Health (MPH), Certificate No. 06081545 on 2006.  

 Dr. Denis Nunez Sanchez, FNP-BC, holds a Master of Science in Nursing from Florida International University, and Board Certified Nurse Practitioner in Family Medicine.  He is also a Foreign Educated physician who completed the medical doctorate degree at the Superior Institute of Medical Science, Camaguey, Cuba, specialized  in Internal Medicine. 

1. Family Nurse Practitioner BC (ANCC Certification), License ARNP 9357574, National Provider Identifier: 1235534546.  Registered Nurse, State of Florida. License RN 9357574. Foreign Educated Internal Medicine specialist, 2004. Foreign Educated General Physician, 1999.

Dr. Denis Nunez Sanchez is the director of research at Biomolecular LLC. He serves as a family nurse practitioner in private institutions related to the field of science and technology. Dr. Denis has over 20 years of experience in the medical field. He also  shares a passion for teaching where he taught as a nursing science professor at Dade Medical College, online campus: June 2012 – October 2015.   Served at Campbell Urgent Care August /2011- January /2013, as a  medical staff scribe.  Served at Any Lab Test Now July 2010/ September 2011 as a  medical assistant. Dr. Denis worked in the  General Medical Clinic, PA- January 2008/ Nov 2008  as a medical assistant.  Worked in Las Tunas General Hospital/Cuba Sept 2001/January 2007 as an internal medicine doctor,  internal medicine professor, and  internal medicine director. Worked as a general physician at the  Majibacoa Rural Hospital/Cuba Sept 1999/August 2001.

1. United States Patent and Trademark Office, 2012, U.S. Patent. reference application No. 61/619,352, entitled Bio-Cellular Treatments for Diabetes Mellitus.